Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30033364.
- Also identified by DOI 10.1016/j.cell.2018.06.013 and PMC identifier 6086726.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bacteria utilize CRISPR-Cas adaptive immune systems for protection from bacteriophages (phages), and some phages produce anti-CRISPR (Acr) proteins that inhibit immune function. Despite thorough mechanistic and structural information for some Acr proteins, how they are deployed and utilized by a phage during infection is unknown. Here, we show that Acr production does not guarantee phage replication when faced with CRISPR-Cas immunity, but instead, infections fail when phage population numbers fall below a critical threshold. Infections succeed only if a sufficient Acr dose is contributed to a single cell by multiple phage genomes. The production of Acr proteins by phage genomes that fail to replicate leave the cell immunosuppressed, which predisposes the cell for successful infection by other phages in the population. This altruistic mechanism for CRISPR-Cas inhibition demonstrates inter-virus cooperation that may also manifest in other host-parasite interactions.
Medical subject headings
- Bacteriophages
- CRISPR-Cas Systems
- Host-Pathogen Interactions
- Pseudomonas aeruginosa
- Viral Proteins